Guoan Chen Selected Research

polyacrylamide

7/2004	The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis.
3/2004	Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.
3/2004	Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas.
11/2003	Protein profiles associated with survival in lung adenocarcinoma.
4/2003	Proteomic analysis of eIF-5A in lung adenocarcinomas.
9/2002	Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma.
4/2002	Discordant protein and mRNA expression in lung adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guoan Chen Research Topics

Disease

65	Neoplasms (Cancer) 06/2022 - 04/2002
38	Adenocarcinoma of Lung 01/2022 - 04/2002
37	Lung Neoplasms (Lung Cancer) 06/2022 - 12/2002
9	Carcinogenesis 10/2021 - 08/2005
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2008
7	Adenocarcinoma 10/2019 - 11/2003
5	Multiple Myeloma 12/2019 - 12/2013
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2022 - 09/2021
4	Neoplasm Metastasis (Metastasis) 01/2019 - 08/2005
3	Carcinoma (Carcinomatosis) 01/2019 - 04/2009
2	Thrombocytopenia (Thrombopenia) 03/2022 - 01/2022
2	Fever (Fevers) 01/2020 - 04/2014
2	Breast Neoplasms (Breast Cancer) 10/2019 - 08/2014
2	Leukemia 01/2018 - 12/2016
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2017 - 12/2016
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 03/2022
1	Hemorrhage 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Cicatrix (Scar) 10/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2021
1	Colonic Neoplasms (Colon Cancer) 03/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 10/2020
1	COVID-19 01/2020
1	Hypoxia (Hypoxemia) 10/2019

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 03/2021 - 04/2002
21	Messenger RNA (mRNA)IBA 11/2020 - 04/2002
20	Biomarkers (Surrogate Marker)IBA 08/2021 - 07/2002
11	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2009
10	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2015
8	EnzymesIBA 08/2021 - 07/2002
8	Protein Isoforms (Isoforms)IBA 07/2013 - 07/2002
7	Long Noncoding RNAIBA 01/2022 - 01/2017
7	polyacrylamideIBA 07/2004 - 04/2002
5	OligonucleotidesIBA 04/2009 - 12/2002
4	Inosine Triphosphate (ITP)IBA 03/2022 - 09/2021
4	Small Interfering RNA (siRNA)IBA 12/2020 - 07/2011
4	pevonedistatIBA 01/2020 - 02/2014
4	Biological ProductsIBA 06/2019 - 03/2004
3	Ligases (Synthetase)IBA 01/2020 - 02/2014
3	Vitamin D3 24-HydroxylaseIBA 01/2020 - 02/2011
3	Phosphotransferases (Kinase)IBA 10/2019 - 09/2003
3	Pharmaceutical PreparationsIBA 12/2013 - 02/2003
2	Beclin-1IBA 06/2022 - 01/2020
2	Circular RNAIBA 06/2021 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021 - 10/2016
2	Vincristine (Oncovin)FDA LinkGeneric 05/2021 - 10/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2021 - 10/2016
2	Protein Kinases (Protein Kinase)IBA 01/2020 - 08/2012
2	Cullin Proteins (Cullins)IBA 01/2020 - 07/2019
2	AntibodiesIBA 01/2020 - 04/2007
2	UbiquitinIBA 01/2020 - 04/2007
2	Untranslated RNA (Noncoding RNA)IBA 12/2019 - 03/2016
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2019 - 02/2014
2	LigandsIBA 01/2019 - 04/2013
2	CyclinsIBA 01/2017 - 08/2005
2	Oncogene Proteins (Oncogene Protein)IBA 05/2014 - 09/2003
2	Checkpoint Kinase 1IBA 03/2014 - 12/2013
2	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 11/2013
2	Selenium-Binding ProteinsIBA 04/2010 - 03/2004
2	AutoantibodiesIBA 11/2008 - 04/2007
1	icotinibIBA 06/2022
1	Gefitinib (Iressa)FDA Link 06/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	Thrombopoietin ReceptorsIBA 01/2022
1	hetrombopagIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2021
1	LanthanumIBA 10/2021
1	StearatesIBA 10/2021
1	CollagenIBA 08/2021
1	Prednisolone (Predate)FDA LinkGeneric 05/2021
1	Rituximab (Mabthera)FDA Link 05/2021
1	BRCA1 ProteinIBA 03/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2020
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2020
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2020
1	AMP-Activated Protein KinasesIBA 01/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2020
1	Cytochrome P450 Family 24IBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Anaphase-Promoting Complex-CyclosomeIBA 01/2020
1	Green Fluorescent ProteinsIBA 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020
1	Red Fluorescent ProteinIBA 01/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2020
1	bafilomycin A1IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Tamoxifen FDA LinkGeneric 10/2019
1	B7-H1 AntigenIBA 01/2019
1	lonidamineIBA 01/2019

Therapy/Procedure

10	Therapeutics 06/2022 - 08/2002
4	Drug Therapy (Chemotherapy) 05/2021 - 03/2014
2	Immunotherapy 01/2019 - 06/2018
2	Lasers (Laser) 01/2008 - 07/2005
1	Transplantation 03/2021